Neurofibromatosis type II is an inherited autosomal dominant syndrome, characterized by multiple neoplasms of the central and peripheral nervous system associated with ocular abnormalities. The most common tumor associated with the disease is the vestibulocochlear schwannoma, and as many as 10% of patients with this tumor have neurofibromatosis type 2. In this report, we aim to present a 36-year-old female who presented with chief complaints of unilateral tinnitus, and, during her workup, which included cranial and whole spine magnetic resonance imaging, we found bilateral acoustic neuroma with multiple meningiomas. Based on clinical and imaging findings, the diagnosis of neurofibromatosis type 2 was made.
Neurofibromatosis 2. Otolaryngol Clin N Am 2012;45(3):315–332.
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29(12):841–846.
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;75(4):826.
Neurofibromatosis type 2. Lancet 2009;373(9679):1974–1986.
A clinical study of type 2 neurofibromatosis. QJ Med 1992;84(304):603–618.
Case of tumours in the skull, dura mater, and brain. Edinburgh Med Surg J 1822;18(1):393–397.
The diagnostic evaluation and multidisciplinary management of NF1 and NF2. JAMA 1997;278(1):51–57.
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54(7):71–76.
Birth incidence and prevalence of tumor prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010;152A(2):327–332.
Neurotology. Mosby Year Book Inc 1994:131–144.
Arachnoid cysts of the petrous apex in a patient with vestibular schwannoma. Otolaryngol Head Neck Surg 2000;123(5):657–658.
Preoperative predictive factors for hearing preservation in vestibular schwannoma surgery. Ann Otol Rhinol Laryngol 2006;115(1):41–46.
Acoustic neuromas and neurofibromatosis type 2. Otology and Neurotology 2001;4:351–369.
Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Brit J Neurosurg 2005;19(1):5–12.